ArticleCell death & disease2021

Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling.

Zhipeng Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.